160 related articles for article (PubMed ID: 10029819)
1. Transient hypoplastic anemia caused by primary human parvovirus B19 infection in a previously untreated patient with hemophilia transfused with a plasma-derived, monoclonal antibody-purified factor VIII concentrate.
Matsui H; Sugimoto M; Tsuji S; Shima M; Giddings J; Yoshioka A
J Pediatr Hematol Oncol; 1999; 21(1):74-6. PubMed ID: 10029819
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of IgG antibodies to human parvovirus B19 in haemophilia children treated with recombinant factor (F)VIII only or with at least one plasma-derived FVIII or FIX concentrate: results from the French haemophilia cohort.
Gaboulaud V; Parquet A; Tahiri C; Claeyssens S; Potard V; Faradji A; Peynet J; Costagliola D;
Br J Haematol; 2002 Feb; 116(2):383-9. PubMed ID: 11841442
[TBL] [Abstract][Full Text] [Related]
3. Human parvovirus B19 in young male patients with hemophilia A: associations with treatment product exposure and joint range-of-motion limitation.
Soucie JM; Siwak EB; Hooper WC; Evatt BL; Hollinger FB;
Transfusion; 2004 Aug; 44(8):1179-85. PubMed ID: 15265122
[TBL] [Abstract][Full Text] [Related]
4. Transmission of human parvovirus B19 by plasma derived factor VIII concentrates.
Laurian Y; Dussaix E; Parquet A; Chalvon-Demersay A; d'Oiron R; Tchernia G
Nouv Rev Fr Hematol (1978); 1994 Dec; 36(6):449-53. PubMed ID: 7753615
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of nucleic acid sequences specific for human parvoviruses, hepatitis A and hepatitis E viruses in coagulation factor concentrates.
Modrow S; Wenzel JJ; Schimanski S; Schwarzbeck J; Rothe U; Oldenburg J; Jilg W; Eis-Hübinger AM
Vox Sang; 2011 May; 100(4):351-8. PubMed ID: 21133933
[TBL] [Abstract][Full Text] [Related]
6. A child with human parvovirus B19 infection induced aplastic anemia and acute hepatitis: effectiveness of immunosuppressive therapy.
Al-Abdwani RM; Khamis FA; Balkhair A; Sacharia M; Wali YA
Pediatr Hematol Oncol; 2008 Sep; 25(7):699-703. PubMed ID: 18850484
[TBL] [Abstract][Full Text] [Related]
7. Human parvovirus B19 in patients with aplastic anemia.
Mishra B; Malhotra P; Ratho RK; Singh MP; Varma S; Varma N
Am J Hematol; 2005 Jun; 79(2):166-7. PubMed ID: 15929106
[TBL] [Abstract][Full Text] [Related]
8. Parvovirus B19 transmission by a high-purity factor VIII concentrate.
Wu CG; Mason B; Jong J; Erdman D; McKernan L; Oakley M; Soucie M; Evatt B; Yu MY
Transfusion; 2005 Jun; 45(6):1003-10. PubMed ID: 15935000
[TBL] [Abstract][Full Text] [Related]
9. Transmission of parvovirus B19 by coagulation factor concentrates exposed to 100 degrees C heat after lyophilization.
Santagostino E; Mannucci PM; Gringeri A; Azzi A; Morfini M; Musso R; Santoro R; Schiavoni M
Transfusion; 1997 May; 37(5):517-22. PubMed ID: 9149778
[TBL] [Abstract][Full Text] [Related]
10. Human parvovirus PARV4 in clotting factor VIII concentrates.
Fryer JF; Hubbard AR; Baylis SA
Vox Sang; 2007 Nov; 93(4):341-7. PubMed ID: 18070279
[TBL] [Abstract][Full Text] [Related]
11. Parvovirus B19 transmission by heat-treated clotting factor concentrates.
Blümel J; Schmidt I; Effenberger W; Seitz H; Willkommen H; Brackmann HH; Löwer J; Eis-Hübinger AM
Transfusion; 2002 Nov; 42(11):1473-81. PubMed ID: 12421221
[TBL] [Abstract][Full Text] [Related]
12. Effects of transfusion on human erythrovirus B19-susceptible or -infected pediatric recipients in a genotype 3-endemic area.
Parsyan A; Addo-Yobo E; Owusu-Ofori S; Akpene H; Sarkodie F; Allain JP
Transfusion; 2006 Sep; 46(9):1593-600. PubMed ID: 16965589
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a new LightCycler reverse transcription-polymerase chain reaction infectivity assay for detection of human parvovirus B19 in dry-heat inactivation studies.
Prikhod'ko GG; Vasilyeva I; Reyes H; Wong S; Brown KE; Jameson T; Busby TF
Transfusion; 2005 Jun; 45(6):1011-9. PubMed ID: 15935001
[TBL] [Abstract][Full Text] [Related]
14. Pasteurized, monoclonal antibody factor VIII concentrate: establishing a new standard for purity and viral safety of plasma-derived concentrates.
Goldsmith JC
Blood Coagul Fibrinolysis; 2000 Mar; 11(2):203-15. PubMed ID: 10759015
[TBL] [Abstract][Full Text] [Related]
15. Transient aplastic anemia caused by parvovirus B19 infection in a heart transplant recipient.
Bergen GA; Sakalosky PE; Sinnott JT
J Heart Lung Transplant; 1996 Aug; 15(8):843-5. PubMed ID: 8878766
[TBL] [Abstract][Full Text] [Related]
16. [Human parvovirus B19 infection mimicking systemic lupus erythematosus: case report].
Banno S; Matsumoto Y; Sugiura Y; Ueda R
Ryumachi; 1997 Aug; 37(4):581-6. PubMed ID: 9311285
[TBL] [Abstract][Full Text] [Related]
17. Parvovirus B19 infection associated with severe aplastic anemia in an immunocompetent patient.
Yetgin S; Cetin M; Ozyürek E; Aslan D; Uçkan D
Pediatr Hematol Oncol; 2004; 21(3):223-6. PubMed ID: 15202161
[TBL] [Abstract][Full Text] [Related]
18. [Transient myelodysplasia associated with human parvovirus B19 infection in a child without underlying disease].
Tezuka T; Sugita K; Sato H; Uno K; Yamakawa N; Goi K; Inukai T; Nakazawa S
Rinsho Ketsueki; 2001 Nov; 42(11):1096-100. PubMed ID: 11808077
[TBL] [Abstract][Full Text] [Related]
19. Human parvovirus B 19 and Epstein-Barr virus co-infection in a child with hereditary spherocytosis.
Cefalo MG; Arlotta A; Maurizi P; Russo I; Sani I; Battista A; Mastrangelo S; Ruggiero A; Riccardi R
Eur Rev Med Pharmacol Sci; 2012 Feb; 16(2):265-9. PubMed ID: 22428480
[TBL] [Abstract][Full Text] [Related]
20. Hypoplastic anemia in a hemophiliac first infused with a solvent/detergent treated factor VIII concentrate: the role of human B19 parvovirus.
Morfini M; Longo G; Rossi Ferrini P; Azzi A; Zakrewska C; Ciappi S; Kolumban P
Am J Hematol; 1992 Feb; 39(2):149-50. PubMed ID: 1550108
[No Abstract] [Full Text] [Related]
[Next] [New Search]
